Most Read News
- Where do you start when developing a new medicine?
- New therapeutic target discovered for Alzheimer's disease
- Novartis announces US FDA approval of Xolair® for chronic idiopathic urticaria
- New technique brings us closer to HIV and hepatitis C vaccines
- Novo Nordisk launches 'Cities Changing Diabetes' to fight urban diabetes
- AstraZeneca and MRC enter strategic collaboration
- First comprehensive atlas of human gene activity released
Company Profiles and News
Abbott |
Amgen |
AstraZeneca |
Bayer |
Boehringer Ingelheim |
Bristol-Myers Squibb |
Daiichi Sankyo |
Eli Lilly and Company |
Genzyme |
GlaxoSmithKline |
Lundbeck |
Merck |
Merck KGaA |
Novartis |
Novo Nordisk |
Nycomed |
Pfizer |
Roche |
Sanofi |
Shire |
Takeda |
UCB | ...
Showcase your Company Profile / News
Showcase your Company Profile / News
Pharmaceutical Companies
Business & Industry News
- Abbott reports first-quarter 2014 results
- Roche with good start in 2014
- Abbott completes enrollment of Absorb™ randomized clinical trials in the United States, Japan and China
- Novartis and Malaria No More provide two million antimalarial treatments to children in Zambia
- Merck Serono enters into research agreement with Pfizer and Broad Institute
- Bayer HealthCare to significantly increase production capacity in China
- AstraZeneca and MRC enter strategic collaboration
Research & Development News
- Enzyme revealed as promising target to treat asthma and cancer
- Virus-fighting genes linked to mutations in cancer
- Yeast provides genetic clues on drug response
- Cancer's thirst for copper can be targeted
- Experimental drug shows promise for treatment-resistant leukemias
- Caffeine against Alzheimer's disease
- Zombie cancer cells eat themselves to live
Regulatory Affairs News
- FDA requires removal of certain restrictions on the diabetes drug Avandia
- EMA and US FDA release first conclusions of parallel assessment of quality-by-design applications
- FDA approves new drug to treat HIV infection
- FDA alerts companies to stop illegal sale of treatments for diabetes
- FDA takes action to protect consumers from dangerous medicines sold by illegal online pharmacies
- FDA obtains waiver from European Commission to facilitate export for U.S. pharmaceutical manufacturers
- FDA budget requests $4.7 billion